BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28594133)

  • 1. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
    Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
    Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract.
    Chapman-Fredricks J; Younes SF; Fan YS; Sandoval-Sus JD; Natkunam Y; Lossos IS
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):200-4. PubMed ID: 22914613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
    Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
    Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
    Moore EM; Swerdlow SH; Gibson SE
    Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
    Younes SF; Beck AH; Ohgami RS; Lossos IS; Levy R; Warnke RA; Natkunam Y
    Am J Clin Pathol; 2011 May; 135(5):697-708. PubMed ID: 21502424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
    Xie X; Sundram U; Natkunam Y; Kohler S; Hoppe RT; Kim YH; Cook JR; Hammel J; Swerdlow SH; Guitart J; Smith MD; Bosler D; Listinsky C; Lossos IS; Hsi ED
    Mod Pathol; 2008 Jun; 21(6):653-9. PubMed ID: 18264083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.
    Younes SF; Beck AH; Lossos IS; Levy R; Warnke RA; Natkunam Y
    Am J Surg Pathol; 2010 Sep; 34(9):1266-76. PubMed ID: 20697248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.
    Vergier B; Belaud-Rotureau MA; Benassy MN; Beylot-Barry M; Dubus P; Delaunay M; Garroste JC; Taine L; Merlio JP
    Am J Surg Pathol; 2004 Jun; 28(6):748-55. PubMed ID: 15166666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma.
    Berker N; Yeğen G; Özlük Y; Doğan Ö
    Turk J Haematol; 2023 Aug; 40(3):162-173. PubMed ID: 37519110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups.
    Marafioti T; Copie-Bergman C; Calaminici M; Paterson JC; Shende VH; Liu H; Baia M; Ramsay AD; Agostinelli C; Brière J; Clear A; Du MQ; Piccaluga PP; Masir N; Nacheva EP; Sujobert P; Shanmugam K; Grogan TM; Brooks SP; Khwaja A; Ardeshna K; Townsend W; Pileri SA; Haioun C; Linch D; Gribben JG; Gaulard P; Isaacson PG
    Histopathology; 2013 May; 62(6):860-75. PubMed ID: 23509938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of HGAL and LMO2 in follicular lymphoma].
    Zhang F; Luo D; Luo X; Chen Y; Xu J; Chen J; Zhuang H; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Feb; 45(2):83-5. PubMed ID: 26879427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
    Siddiqi IN; Friedman J; Barry-Holson KQ; Ma C; Thodima V; Kang I; Padmanabhan R; Dias LM; Kelly KR; Brynes RK; Kamalakaran S; Houldsworth J
    Mod Pathol; 2016 Jun; 29(6):570-81. PubMed ID: 26965583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms.
    Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
    Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
    Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
    Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
    J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas.
    Streubel B; Scheucher B; Valencak J; Huber D; Petzelbauer P; Trautinger F; Weihsengruber F; Mannhalter C; Cerroni L; Chott A
    Am J Surg Pathol; 2006 Apr; 30(4):529-36. PubMed ID: 16625101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.